​

Tyra Biosciences (TYRA) Stock Forecast, Price Target & Predictions

OverviewOwnershipFinancialsChart

TYRA Stock Forecast

Tyra Biosciences (TYRA) stock forecast, based on 7 Wall Street analysts, predicts a 12-month average price target of $49.80, with a high of $59.00 and a low of $42.00. This represents a 58.95% increase from the last price of $31.33.

$10 $20 $30 $40 $50 $60 High: $59 Avg: $49.8 Low: $42 Last Closed Price: $31.33

TYRA Stock Rating

Tyra Biosciences stock's rating consensus is Buy, based on 7 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 7 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 7 0 7 Strong Sell Sell Hold Buy Strong Buy

TYRA Price Target Upside V Benchmarks

TypeNameUpside
StockTyra Biosciences58.95%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts567
Avg Price Target$49.80$47.67$46.00
Last Closing Price$31.33$31.33$31.33
Upside/Downside58.95%52.15%46.82%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Feb, 2627---9
Jan, 2617---8
Dec, 2517---8
Nov, 2526---8
Oct, 2527---9
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Feb 17, 2026Mitchell KapoorH.C. Wainwright$45.00$27.9960.77%43.63%
Feb 13, 2026Robert DriscollWedbush$53.00$30.1076.08%69.17%
Feb 03, 2026Oppenheimer$50.00$31.7257.63%59.59%
Jan 27, 2026Barclays$59.00$31.4087.90%88.32%
Jan 23, 2026Piper Sandler$42.00$30.9135.88%34.06%
Dec 16, 2025Robert DriscollWedbush$37.00$22.1167.35%18.10%
Sep 10, 2025Matthew BieglerOppenheimer$36.00$12.18195.57%14.91%
Nov 11, 2024Mitchell KapoorH.C. Wainwright$30.00$16.7079.64%-4.25%
Oct 18, 2024Jason ZemanskyBank of America Securities$31.00$25.9819.32%-1.05%
Sep 19, 2024Matt BieglerOppenheimer$33.00$24.6533.87%5.33%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Feb 17, 2026H.C. WainwrightBuyBuyhold
Feb 13, 2026WedbushOutperformOutperformhold
Feb 10, 2026William BlairOutperforminitialise
Feb 03, 2026OppenheimerOutperformOutperformhold
Jan 27, 2026BarclaysOverweightinitialise
Jan 23, 2026Piper SandlerOverweightOverweighthold
Dec 16, 2025WedbushOutperformOutperformhold
Sep 10, 2025OppenheimerOutperformOutperformhold
Sep 02, 2025Raymond JamesStrong Buyinitialise
Oct 18, 2024Bank of America SecuritiesBuyupgrade

Financial Forecast

EPS Forecast

Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-1.62$-1.51----
Avg Forecast$-1.58$-1.56$-2.04$-2.23$-1.85$-1.28
High Forecast$-1.53$-1.49$-1.81$-1.75$-0.90$-1.28
Low Forecast$-1.65$-1.64$-2.20$-2.75$-2.23$-1.28
Surprise %2.53%-3.21%----

Revenue Forecast

$0 $30M $60M $90M $120M $150M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported------
Avg Forecast---$1.20M$23.36M$113.45M
High Forecast---$1.20M$23.36M$113.45M
Low Forecast---$1.20M$23.36M$113.45M
Surprise %------

Net Income Forecast

$-120M $-103M $-86M $-69M $-52M $-35M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-69.13M$-86.48M----
Avg Forecast$-69.13M$-66.94M$-85.64M$-96.09M$-66.93M$-54.66M
High Forecast$-65.20M$-63.76M$-77.12M$-74.73M$-38.42M$-54.66M
Low Forecast$-70.31M$-70.13M$-94.16M$-117.44M$-95.44M$-54.66M
Surprise %-29.19%----

TYRA Forecast FAQ

Is Tyra Biosciences stock a buy?

Tyra Biosciences stock has a consensus rating of Buy, based on 7 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 7 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Tyra Biosciences is a favorable investment for most analysts.

What is Tyra Biosciences's price target?

Tyra Biosciences's price target, set by 7 Wall Street analysts, averages $49.8 over the next 12 months. The price target range spans from $42 at the low end to $59 at the high end, suggesting a potential 58.95% change from the previous closing price of $31.33.

How does Tyra Biosciences stock forecast compare to its benchmarks?

Tyra Biosciences's stock forecast shows a 58.95% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for Tyra Biosciences over the past three months?

  • February 2026: 22.22% Strong Buy, 77.78% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • January 2026: 12.50% Strong Buy, 87.50% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • December 2025: 12.50% Strong Buy, 87.50% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Tyra Biosciences’s EPS forecast?

Tyra Biosciences's average annual EPS forecast for its fiscal year ending in December 2025 is $-2.04, marking a 35.10% increase from the reported $-1.51 in 2024. Estimates for the following years are $-2.23 in 2026, $-1.85 in 2027, and $-1.28 in 2028.

What is Tyra Biosciences’s revenue forecast?

Tyra Biosciences's average annual revenue forecast for its fiscal year ending in December 2025 is $0, reflecting a 0% decrease from the reported $0 in 2024. The forecast for 2026 is $1.2M, followed by $23.36M for 2027, and $113.45M for 2028.

What is Tyra Biosciences’s net income forecast?

Tyra Biosciences's net income forecast for the fiscal year ending in December 2025 stands at $-85.642M, representing a -0.97% decrease from the reported $-86.481M in 2024. Projections indicate $-96.086M in 2026, $-66.931M in 2027, and $-54.662M in 2028.